Dr. Nasser Mohamed is believed to be the first physician to offer Apretude (injectable PrEP) in San Francisco outside of a clinical trial.Mohamed, a gay man, founded Osra Medical in 2019 "to take back my relationship with my patients and empower myself to be the doctor I set out to be," his website states.The medical center in the city's Lower Pacific Heights neighborhood strives to improve health outcomes for the LGBTQ+ community by offering access to comprehensive primary care, a news release states.
Mohamed stated that the advent of injectable PrEP is important."I am really excited to utilize my resources to adapt cutting-edge HIV prevention methods and to be among the first to bring it to my community," he stated.The federal Food and Drug Administration approved Apretude last December, as the Bay Area Reporter previously reported.
Apretude (extended-release cabotegravir) is the first long-acting injectable option for HIV prevention. The shots, which are administered by a health care provider every two months, were more effective than daily PrEP pills in two large studies of gay men, trans women, and cisgender women.The San Francisco AIDS Foundation also plans to offer Apretude, according to a recent newsletter.
Mohamed is a member of the Golden Gate Business Association, an LGBTQ chamber of commerce. Osra Medical is a member of the National LGBT Chamber of Commerce and a certified LGBT Business Enterprise.